| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| T-Lymphocytes, Regulatory | 87 | 2024 | 3116 | 9.420 |
Why?
|
| Thymus Gland | 75 | 2024 | 1266 | 8.260 |
Why?
|
| Histocompatibility Antigens Class II | 75 | 2017 | 1439 | 4.760 |
Why?
|
| Intra-Abdominal Fat | 14 | 2024 | 624 | 4.440 |
Why?
|
| T-Lymphocytes | 98 | 2024 | 10276 | 3.880 |
Why?
|
| Immune Tolerance | 30 | 2024 | 2323 | 3.580 |
Why?
|
| Diabetes Mellitus, Type 1 | 61 | 2021 | 3447 | 3.250 |
Why?
|
| Transcription Factors | 60 | 2024 | 12174 | 3.130 |
Why?
|
| Autoimmunity | 41 | 2022 | 1360 | 2.910 |
Why?
|
| Mice, Inbred NOD | 81 | 2023 | 1839 | 2.900 |
Why?
|
| Receptors, Antigen, T-Cell | 59 | 2023 | 2574 | 2.520 |
Why?
|
| Mice | 333 | 2025 | 82074 | 2.460 |
Why?
|
| Forkhead Transcription Factors | 41 | 2024 | 1625 | 2.420 |
Why?
|
| CD4-Positive T-Lymphocytes | 61 | 2021 | 4413 | 2.340 |
Why?
|
| Epithelial Cells | 20 | 2024 | 3701 | 2.320 |
Why?
|
| Islets of Langerhans | 32 | 2019 | 1351 | 2.090 |
Why?
|
| Genes, MHC Class II | 33 | 2007 | 433 | 2.050 |
Why?
|
| Animals | 373 | 2025 | 169408 | 1.980 |
Why?
|
| Polyendocrinopathies, Autoimmune | 9 | 2020 | 56 | 1.970 |
Why?
|
| Mice, Transgenic | 106 | 2022 | 9564 | 1.970 |
Why?
|
| Adipose Tissue | 12 | 2024 | 3335 | 1.950 |
Why?
|
| T-Lymphocyte Subsets | 24 | 2021 | 1813 | 1.730 |
Why?
|
| Cell Differentiation | 63 | 2024 | 11684 | 1.710 |
Why?
|
| Arthritis | 15 | 2012 | 684 | 1.690 |
Why?
|
| Muscle, Skeletal | 10 | 2023 | 4980 | 1.640 |
Why?
|
| Autoimmune Diseases | 31 | 2017 | 2260 | 1.640 |
Why?
|
| Regeneration | 8 | 2022 | 1524 | 1.590 |
Why?
|
| Arthritis, Experimental | 14 | 2016 | 293 | 1.560 |
Why?
|
| Mice, Inbred C57BL | 96 | 2025 | 22381 | 1.550 |
Why?
|
| Self Tolerance | 11 | 2015 | 122 | 1.470 |
Why?
|
| Gene Expression Regulation | 55 | 2025 | 11934 | 1.460 |
Why?
|
| B-Lymphocytes | 32 | 2024 | 4794 | 1.360 |
Why?
|
| Adipocytes | 7 | 2024 | 1199 | 1.340 |
Why?
|
| Inflammation | 33 | 2025 | 10869 | 1.230 |
Why?
|
| Homeostasis | 14 | 2024 | 3348 | 1.200 |
Why?
|
| Autoantigens | 18 | 2010 | 891 | 1.180 |
Why?
|
| Interleukin-17 | 5 | 2022 | 925 | 1.150 |
Why?
|
| Major Histocompatibility Complex | 23 | 2005 | 877 | 1.120 |
Why?
|
| Clonal Deletion | 10 | 2012 | 75 | 1.090 |
Why?
|
| Receptors, Antigen, T-Cell, alpha-beta | 21 | 2013 | 812 | 1.080 |
Why?
|
| Spleen | 15 | 2021 | 2294 | 1.030 |
Why?
|
| Models, Immunological | 13 | 2021 | 518 | 1.020 |
Why?
|
| Arthritis, Rheumatoid | 18 | 2013 | 3780 | 0.980 |
Why?
|
| Killer Cells, Natural | 9 | 2025 | 2211 | 0.970 |
Why?
|
| Nuclear Receptor Subfamily 1, Group F, Member 3 | 8 | 2024 | 151 | 0.960 |
Why?
|
| Colon | 6 | 2023 | 1804 | 0.950 |
Why?
|
| DNA, Z-Form | 1 | 2024 | 3 | 0.930 |
Why?
|
| Autoantibodies | 20 | 2012 | 2126 | 0.930 |
Why?
|
| Transcription, Genetic | 36 | 2025 | 7609 | 0.890 |
Why?
|
| Mice, Knockout | 55 | 2024 | 14485 | 0.870 |
Why?
|
| Insulin-Secreting Cells | 9 | 2019 | 899 | 0.870 |
Why?
|
| Hepatocyte Nuclear Factor 4 | 1 | 2023 | 127 | 0.840 |
Why?
|
| PPAR gamma | 3 | 2018 | 487 | 0.830 |
Why?
|
| Complement System Proteins | 3 | 2022 | 738 | 0.820 |
Why?
|
| Mesenchymal Stem Cells | 3 | 2023 | 1672 | 0.810 |
Why?
|
| CD8-Positive T-Lymphocytes | 28 | 2017 | 4651 | 0.790 |
Why?
|
| Species Specificity | 7 | 2024 | 2419 | 0.780 |
Why?
|
| Macrophages | 13 | 2024 | 5800 | 0.750 |
Why?
|
| Receptors, Antigen, T-Cell, gamma-delta | 4 | 2022 | 354 | 0.740 |
Why?
|
| Lymphocyte Activation | 31 | 2022 | 5505 | 0.730 |
Why?
|
| Metagenome | 4 | 2012 | 465 | 0.730 |
Why?
|
| Interferon-gamma | 12 | 2023 | 3163 | 0.720 |
Why?
|
| Disease Models, Animal | 40 | 2021 | 18366 | 0.720 |
Why?
|
| Gene Expression Profiling | 38 | 2024 | 9549 | 0.720 |
Why?
|
| Immune System | 6 | 2019 | 800 | 0.700 |
Why?
|
| Muscle Development | 1 | 2022 | 258 | 0.690 |
Why?
|
| Nociceptors | 2 | 2024 | 460 | 0.690 |
Why?
|
| Glucose-6-Phosphate Isomerase | 9 | 2010 | 49 | 0.690 |
Why?
|
| PPAR alpha | 1 | 2021 | 177 | 0.670 |
Why?
|
| Obesity | 13 | 2024 | 13087 | 0.660 |
Why?
|
| Chromatin | 11 | 2024 | 2981 | 0.660 |
Why?
|
| Th17 Cells | 6 | 2024 | 791 | 0.660 |
Why?
|
| Insulin Resistance | 6 | 2024 | 3982 | 0.660 |
Why?
|
| Immunologic Memory | 12 | 2019 | 1378 | 0.640 |
Why?
|
| Antigen Presentation | 13 | 2017 | 1252 | 0.630 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 8 | 2000 | 318 | 0.620 |
Why?
|
| Promoter Regions, Genetic | 16 | 2024 | 5801 | 0.620 |
Why?
|
| Clonal Anergy | 1 | 2019 | 169 | 0.620 |
Why?
|
| DNA Nucleotidylexotransferase | 8 | 1996 | 64 | 0.600 |
Why?
|
| Digestive System | 2 | 2020 | 244 | 0.590 |
Why?
|
| Lymphocytes | 8 | 2025 | 2614 | 0.590 |
Why?
|
| Mice, Mutant Strains | 19 | 2014 | 1755 | 0.580 |
Why?
|
| Antigen-Presenting Cells | 17 | 2003 | 962 | 0.580 |
Why?
|
| DNA-Binding Proteins | 23 | 2020 | 9618 | 0.570 |
Why?
|
| Molecular Sequence Data | 54 | 2015 | 17629 | 0.560 |
Why?
|
| Intestines | 7 | 2024 | 1911 | 0.560 |
Why?
|
| Interferon-alpha | 1 | 2021 | 910 | 0.550 |
Why?
|
| Enhancer Elements, Genetic | 6 | 2017 | 1369 | 0.550 |
Why?
|
| Pancreas | 16 | 2017 | 1700 | 0.550 |
Why?
|
| Antigens, Differentiation | 5 | 2006 | 921 | 0.540 |
Why?
|
| DNA Topoisomerases, Type I | 1 | 2017 | 108 | 0.540 |
Why?
|
| Single-Cell Analysis | 10 | 2024 | 2542 | 0.530 |
Why?
|
| Cell Lineage | 19 | 2014 | 2576 | 0.530 |
Why?
|
| Immunity | 4 | 2015 | 1003 | 0.520 |
Why?
|
| Histocompatibility Antigens Class I | 13 | 2001 | 1363 | 0.520 |
Why?
|
| Immunomodulation | 1 | 2020 | 549 | 0.520 |
Why?
|
| Chromatin Assembly and Disassembly | 2 | 2018 | 633 | 0.510 |
Why?
|
| Bacteria | 6 | 2021 | 2219 | 0.510 |
Why?
|
| Stromal Cells | 6 | 2024 | 1337 | 0.500 |
Why?
|
| Cytokines | 16 | 2025 | 7453 | 0.500 |
Why?
|
| Positive Transcriptional Elongation Factor B | 1 | 2015 | 42 | 0.500 |
Why?
|
| Transcriptional Activation | 3 | 2017 | 1750 | 0.490 |
Why?
|
| Receptors, IgG | 4 | 2010 | 564 | 0.490 |
Why?
|
| Diabetes Mellitus, Type 2 | 8 | 2023 | 12252 | 0.490 |
Why?
|
| Gene Expression | 12 | 2016 | 7602 | 0.480 |
Why?
|
| Base Sequence | 44 | 2011 | 12430 | 0.480 |
Why?
|
| Flow Cytometry | 25 | 2021 | 5905 | 0.470 |
Why?
|
| Antigens, CD | 16 | 2015 | 4032 | 0.460 |
Why?
|
| Dendritic Cells | 6 | 2021 | 2748 | 0.460 |
Why?
|
| H-2 Antigens | 8 | 1997 | 359 | 0.450 |
Why?
|
| Adipose Tissue, Brown | 3 | 2020 | 776 | 0.450 |
Why?
|
| RNA, Messenger | 16 | 2018 | 12809 | 0.450 |
Why?
|
| Mice, Inbred Strains | 14 | 2016 | 1769 | 0.450 |
Why?
|
| Bacteroidaceae Infections | 1 | 2013 | 32 | 0.450 |
Why?
|
| Prevotella | 1 | 2013 | 81 | 0.440 |
Why?
|
| Denervation | 1 | 2014 | 265 | 0.430 |
Why?
|
| Diabetes Mellitus, Experimental | 10 | 2019 | 1124 | 0.430 |
Why?
|
| Peptides | 15 | 2015 | 4353 | 0.420 |
Why?
|
| Zebrafish | 1 | 2024 | 3037 | 0.420 |
Why?
|
| Receptors, Complement | 2 | 2012 | 254 | 0.420 |
Why?
|
| Aging | 6 | 2019 | 8765 | 0.420 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 15 | 2013 | 3811 | 0.410 |
Why?
|
| Mucous Membrane | 1 | 2016 | 659 | 0.410 |
Why?
|
| Amino Acid Sequence | 40 | 2015 | 13427 | 0.410 |
Why?
|
| Lysine | 3 | 2015 | 1000 | 0.410 |
Why?
|
| Cells, Cultured | 19 | 2024 | 19023 | 0.410 |
Why?
|
| Organ Specificity | 9 | 2020 | 1970 | 0.410 |
Why?
|
| Mice, Inbred BALB C | 21 | 2020 | 6232 | 0.400 |
Why?
|
| Hindlimb | 1 | 2014 | 516 | 0.390 |
Why?
|
| Mast Cells | 8 | 2014 | 1406 | 0.390 |
Why?
|
| Receptor, Anaphylatoxin C5a | 2 | 2010 | 87 | 0.390 |
Why?
|
| Interleukin-1alpha | 2 | 2010 | 86 | 0.380 |
Why?
|
| Mice, Obese | 3 | 2024 | 418 | 0.380 |
Why?
|
| Histones | 7 | 2010 | 2603 | 0.370 |
Why?
|
| Antigens, Differentiation, T-Lymphocyte | 7 | 2013 | 896 | 0.370 |
Why?
|
| Lymph Nodes | 15 | 2023 | 3473 | 0.370 |
Why?
|
| Cell Separation | 5 | 2019 | 1728 | 0.370 |
Why?
|
| T-Lymphocytes, Helper-Inducer | 5 | 2010 | 977 | 0.370 |
Why?
|
| Humans | 131 | 2024 | 768887 | 0.360 |
Why?
|
| Circadian Rhythm | 1 | 2022 | 2593 | 0.360 |
Why?
|
| Signal Transduction | 18 | 2024 | 23652 | 0.360 |
Why?
|
| Lymphocyte Function-Associated Antigen-1 | 2 | 2010 | 381 | 0.350 |
Why?
|
| Immunoglobulins | 6 | 2002 | 855 | 0.350 |
Why?
|
| Thinness | 2 | 2014 | 483 | 0.350 |
Why?
|
| Epitopes, T-Lymphocyte | 7 | 2007 | 827 | 0.350 |
Why?
|
| Antigens | 6 | 2023 | 1444 | 0.340 |
Why?
|
| Interleukin-4 | 5 | 2008 | 1157 | 0.340 |
Why?
|
| Allergy and Immunology | 3 | 2012 | 175 | 0.340 |
Why?
|
| Phenotype | 21 | 2021 | 16735 | 0.340 |
Why?
|
| Microvessels | 1 | 2014 | 586 | 0.340 |
Why?
|
| HEK293 Cells | 7 | 2021 | 4291 | 0.340 |
Why?
|
| Protein Binding | 14 | 2017 | 9344 | 0.340 |
Why?
|
| Calcitonin Gene-Related Peptide | 2 | 2024 | 328 | 0.330 |
Why?
|
| Genetic Vectors | 9 | 2006 | 3414 | 0.330 |
Why?
|
| Genome | 4 | 2021 | 1752 | 0.330 |
Why?
|
| Immunity, Innate | 10 | 2017 | 3080 | 0.330 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 7 | 2000 | 792 | 0.320 |
Why?
|
| Neutrophils | 7 | 2023 | 3785 | 0.320 |
Why?
|
| Intestinal Mucosa | 3 | 2016 | 3047 | 0.320 |
Why?
|
| Interleukin-2 | 4 | 2013 | 1895 | 0.320 |
Why?
|
| Antibodies | 8 | 2010 | 2422 | 0.320 |
Why?
|
| Biodiversity | 1 | 2011 | 345 | 0.310 |
Why?
|
| Genetic Variation | 13 | 2024 | 6610 | 0.310 |
Why?
|
| Neuroimmunomodulation | 2 | 2024 | 188 | 0.310 |
Why?
|
| Epitopes | 14 | 1999 | 2529 | 0.310 |
Why?
|
| Male | 66 | 2024 | 365249 | 0.300 |
Why?
|
| Symbiosis | 6 | 2017 | 297 | 0.300 |
Why?
|
| Adipogenesis | 2 | 2024 | 371 | 0.290 |
Why?
|
| Lymphotoxin-alpha | 1 | 2007 | 94 | 0.290 |
Why?
|
| Protein Interaction Domains and Motifs | 2 | 2012 | 450 | 0.280 |
Why?
|
| Lymphocyte Count | 6 | 2012 | 793 | 0.280 |
Why?
|
| Gastrointestinal Tract | 3 | 2022 | 839 | 0.280 |
Why?
|
| Nuclear Proteins | 5 | 2015 | 5803 | 0.280 |
Why?
|
| Cell Communication | 3 | 2020 | 1660 | 0.280 |
Why?
|
| Early Diagnosis | 1 | 2012 | 1195 | 0.270 |
Why?
|
| Organ Culture Techniques | 5 | 2017 | 796 | 0.270 |
Why?
|
| Antibodies, Monoclonal | 14 | 2013 | 9264 | 0.270 |
Why?
|
| Cell Division | 7 | 2004 | 4478 | 0.270 |
Why?
|
| Plasma Cells | 1 | 2010 | 599 | 0.270 |
Why?
|
| Immunologic Deficiency Syndromes | 5 | 2015 | 550 | 0.260 |
Why?
|
| Immunity, Active | 1 | 2006 | 58 | 0.260 |
Why?
|
| Genes, Reporter | 4 | 2014 | 1524 | 0.260 |
Why?
|
| Germ-Free Life | 4 | 2017 | 187 | 0.260 |
Why?
|
| Freund's Adjuvant | 1 | 2006 | 144 | 0.260 |
Why?
|
| Leukocytes | 1 | 2014 | 2034 | 0.260 |
Why?
|
| Hybridomas | 11 | 2003 | 444 | 0.260 |
Why?
|
| Interleukin-1beta | 2 | 2010 | 1027 | 0.260 |
Why?
|
| Interleukin-7 | 3 | 2013 | 146 | 0.250 |
Why?
|
| Alleles | 15 | 2023 | 6901 | 0.250 |
Why?
|
| Complement C3 | 1 | 2007 | 434 | 0.250 |
Why?
|
| Mutation | 31 | 2023 | 30266 | 0.250 |
Why?
|
| Natural Killer T-Cells | 2 | 2013 | 318 | 0.250 |
Why?
|
| beta 2-Microglobulin | 5 | 1999 | 330 | 0.250 |
Why?
|
| Receptors, Antigen, B-Cell | 2 | 2006 | 547 | 0.250 |
Why?
|
| Chromosome Mapping | 12 | 2017 | 4624 | 0.250 |
Why?
|
| Hematopoietic Stem Cells | 4 | 2011 | 3408 | 0.250 |
Why?
|
| Epigenesis, Genetic | 3 | 2017 | 3836 | 0.240 |
Why?
|
| Cell Proliferation | 13 | 2021 | 10486 | 0.240 |
Why?
|
| Endocarditis | 1 | 2009 | 352 | 0.240 |
Why?
|
| Interleukin-6 | 5 | 2025 | 3233 | 0.240 |
Why?
|
| Receptors, Interleukin-2 | 6 | 2006 | 564 | 0.240 |
Why?
|
| Stem Cells | 5 | 2016 | 3540 | 0.240 |
Why?
|
| Recombinant Fusion Proteins | 6 | 2005 | 3744 | 0.240 |
Why?
|
| Chromosomes, Mammalian | 1 | 2005 | 148 | 0.240 |
Why?
|
| Epithelium | 2 | 2008 | 1607 | 0.240 |
Why?
|
| Biological Evolution | 3 | 2024 | 1078 | 0.230 |
Why?
|
| Venoms | 3 | 2015 | 94 | 0.230 |
Why?
|
| Adoptive Transfer | 5 | 2021 | 824 | 0.230 |
Why?
|
| Oncostatin M | 1 | 2024 | 42 | 0.230 |
Why?
|
| Cell Transplantation | 1 | 2006 | 475 | 0.220 |
Why?
|
| DNA Breaks, Double-Stranded | 2 | 2024 | 608 | 0.220 |
Why?
|
| Thermogenesis | 2 | 2020 | 494 | 0.220 |
Why?
|
| Insulin | 10 | 2019 | 6610 | 0.210 |
Why?
|
| Lymphoid Tissue | 5 | 2013 | 446 | 0.210 |
Why?
|
| Female | 55 | 2024 | 397464 | 0.210 |
Why?
|
| Molecular Mimicry | 2 | 2001 | 213 | 0.210 |
Why?
|
| Polymorphism, Genetic | 9 | 1995 | 4251 | 0.210 |
Why?
|
| Coculture Techniques | 2 | 2024 | 1342 | 0.210 |
Why?
|
| Culture Media, Conditioned | 1 | 2024 | 521 | 0.210 |
Why?
|
| HLA-D Antigens | 3 | 1998 | 130 | 0.210 |
Why?
|
| Joints | 6 | 2010 | 324 | 0.210 |
Why?
|
| DNA, Complementary | 5 | 2004 | 1990 | 0.210 |
Why?
|
| TRPV Cation Channels | 1 | 2024 | 244 | 0.200 |
Why?
|
| Myeloid Cells | 2 | 2025 | 840 | 0.200 |
Why?
|
| CpG Islands | 1 | 2007 | 1210 | 0.200 |
Why?
|
| Mitochondria, Muscle | 1 | 2023 | 172 | 0.200 |
Why?
|
| Immunity, Mucosal | 2 | 2016 | 498 | 0.200 |
Why?
|
| Quantitative Trait Loci | 7 | 2015 | 2133 | 0.200 |
Why?
|
| Muramidase | 5 | 2002 | 163 | 0.200 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 7 | 2015 | 4593 | 0.200 |
Why?
|
| Haplotypes | 9 | 2010 | 2725 | 0.200 |
Why?
|
| ARNTL Transcription Factors | 1 | 2022 | 97 | 0.200 |
Why?
|
| Phosphorylation | 6 | 2015 | 8317 | 0.200 |
Why?
|
| Immunotherapy | 2 | 2008 | 4755 | 0.190 |
Why?
|
| Up-Regulation | 6 | 2010 | 4148 | 0.190 |
Why?
|
| Adenoviridae | 4 | 2000 | 1095 | 0.190 |
Why?
|
| Gene Regulatory Networks | 5 | 2017 | 1752 | 0.190 |
Why?
|
| Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 3 | 1999 | 32 | 0.190 |
Why?
|
| Ganglia, Spinal | 1 | 2024 | 530 | 0.190 |
Why?
|
| Binding Sites | 11 | 2017 | 6023 | 0.190 |
Why?
|
| Immunoconjugates | 2 | 2000 | 976 | 0.190 |
Why?
|
| Heligmosomatoidea | 1 | 2021 | 2 | 0.190 |
Why?
|
| Gene Rearrangement, T-Lymphocyte | 4 | 1993 | 111 | 0.190 |
Why?
|
| Polymerase Chain Reaction | 11 | 2016 | 6085 | 0.190 |
Why?
|
| Prediabetic State | 2 | 2008 | 548 | 0.190 |
Why?
|
| Lipolysis | 1 | 2022 | 211 | 0.190 |
Why?
|
| NF-E2-Related Factor 2 | 1 | 2024 | 379 | 0.180 |
Why?
|
| Dermatitis | 1 | 2023 | 203 | 0.180 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2006 | 748 | 0.180 |
Why?
|
| Intestinal Diseases, Parasitic | 1 | 2021 | 64 | 0.180 |
Why?
|
| Nanostructures | 1 | 2005 | 553 | 0.170 |
Why?
|
| RNA Splicing | 3 | 2015 | 905 | 0.170 |
Why?
|
| Receptors, Calcitonin Gene-Related Peptide | 1 | 2020 | 31 | 0.170 |
Why?
|
| Receptors, Cytoplasmic and Nuclear | 1 | 2024 | 859 | 0.170 |
Why?
|
| Succinic Acid | 1 | 2020 | 86 | 0.170 |
Why?
|
| Stearic Acids | 1 | 2019 | 56 | 0.160 |
Why?
|
| Inflammasomes | 1 | 2024 | 540 | 0.160 |
Why?
|
| MAP Kinase Signaling System | 3 | 2015 | 1494 | 0.160 |
Why?
|
| Cell Survival | 5 | 2019 | 5794 | 0.160 |
Why?
|
| Transfection | 8 | 2000 | 5763 | 0.160 |
Why?
|
| Cloning, Molecular | 10 | 1997 | 4168 | 0.160 |
Why?
|
| Gene Deletion | 2 | 2004 | 2674 | 0.160 |
Why?
|
| Genes, Homeobox | 3 | 1989 | 289 | 0.160 |
Why?
|
| Receptors, Interleukin-1 | 2 | 2019 | 260 | 0.160 |
Why?
|
| Protein Isoforms | 2 | 2012 | 1714 | 0.160 |
Why?
|
| Adaptive Immunity | 4 | 2017 | 733 | 0.160 |
Why?
|
| Wound Healing | 2 | 2023 | 2815 | 0.160 |
Why?
|
| Immunogenetic Phenomena | 2 | 2016 | 23 | 0.160 |
Why?
|
| Histocompatibility Antigens | 5 | 2013 | 479 | 0.160 |
Why?
|
| Palmitic Acid | 1 | 2019 | 149 | 0.160 |
Why?
|
| DNA | 18 | 2017 | 7214 | 0.160 |
Why?
|
| Immune System Diseases | 1 | 2021 | 253 | 0.160 |
Why?
|
| Protein Structure, Tertiary | 4 | 2015 | 3775 | 0.150 |
Why?
|
| Janus Kinases | 2 | 2016 | 253 | 0.150 |
Why?
|
| Cardiotoxins | 1 | 2018 | 36 | 0.150 |
Why?
|
| Capsid Proteins | 1 | 2001 | 468 | 0.150 |
Why?
|
| Th2 Cells | 5 | 2012 | 1079 | 0.150 |
Why?
|
| Enteric Nervous System | 1 | 2021 | 213 | 0.150 |
Why?
|
| Gene Transfer Techniques | 2 | 2000 | 1209 | 0.150 |
Why?
|
| Protein Kinase C | 1 | 2002 | 1207 | 0.150 |
Why?
|
| Skin Diseases | 2 | 2023 | 1085 | 0.140 |
Why?
|
| Models, Biological | 5 | 2015 | 9499 | 0.140 |
Why?
|
| Ligands | 7 | 2024 | 3283 | 0.140 |
Why?
|
| Bile Acids and Salts | 1 | 2019 | 400 | 0.140 |
Why?
|
| Proteomics | 3 | 2010 | 3913 | 0.140 |
Why?
|
| Muscles | 1 | 2022 | 1582 | 0.140 |
Why?
|
| Interferon Regulatory Factors | 4 | 2025 | 271 | 0.140 |
Why?
|
| Receptors, Interleukin | 1 | 2018 | 243 | 0.140 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2021 | 391 | 0.140 |
Why?
|
| Interleukin-1 | 3 | 2007 | 1251 | 0.140 |
Why?
|
| Sympathetic Nervous System | 1 | 2020 | 521 | 0.140 |
Why?
|
| Disease Progression | 10 | 2017 | 13677 | 0.140 |
Why?
|
| Immunoblotting | 3 | 2017 | 1647 | 0.140 |
Why?
|
| Transforming Growth Factor beta | 4 | 2013 | 2004 | 0.140 |
Why?
|
| Down-Regulation | 2 | 2021 | 2941 | 0.140 |
Why?
|
| Clostridium | 1 | 2017 | 100 | 0.140 |
Why?
|
| NF-kappa B | 4 | 2025 | 2492 | 0.140 |
Why?
|
| Genes, Dominant | 3 | 2000 | 856 | 0.140 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 6 | 1994 | 288 | 0.140 |
Why?
|
| Energy Metabolism | 2 | 2020 | 2905 | 0.140 |
Why?
|
| Lipoproteins | 1 | 2001 | 880 | 0.130 |
Why?
|
| Amino Acid Substitution | 2 | 2006 | 1741 | 0.130 |
Why?
|
| Retroviridae | 2 | 2006 | 849 | 0.130 |
Why?
|
| Diet | 3 | 2024 | 8090 | 0.130 |
Why?
|
| Immunoglobulin Variable Region | 3 | 1993 | 420 | 0.130 |
Why?
|
| Transgenes | 4 | 2009 | 1016 | 0.130 |
Why?
|
| Antigens, CD1 | 2 | 1995 | 434 | 0.130 |
Why?
|
| Monocytes | 3 | 2014 | 2603 | 0.130 |
Why?
|
| Receptors, Retinoic Acid | 2 | 2024 | 229 | 0.130 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 4 | 2015 | 3814 | 0.130 |
Why?
|
| Kinetics | 6 | 2007 | 6334 | 0.130 |
Why?
|
| Interleukin-15 | 2 | 2010 | 186 | 0.130 |
Why?
|
| Gonadal Steroid Hormones | 1 | 2020 | 708 | 0.130 |
Why?
|
| Genomics | 5 | 2012 | 5928 | 0.130 |
Why?
|
| Mice, Inbred DBA | 4 | 1999 | 624 | 0.130 |
Why?
|
| Guanidines | 1 | 1996 | 194 | 0.120 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2014 | 16051 | 0.120 |
Why?
|
| Antigen-Antibody Complex | 3 | 2009 | 513 | 0.120 |
Why?
|
| Immunosuppressive Agents | 4 | 2009 | 4207 | 0.120 |
Why?
|
| Stochastic Processes | 3 | 2008 | 360 | 0.120 |
Why?
|
| Animals, Newborn | 4 | 1995 | 2695 | 0.120 |
Why?
|
| Maternal-Fetal Exchange | 1 | 2017 | 456 | 0.120 |
Why?
|
| Recombination, Genetic | 4 | 2000 | 1526 | 0.120 |
Why?
|
| Genes, RAG-1 | 1 | 1995 | 68 | 0.120 |
Why?
|
| Mass Spectrometry | 2 | 2014 | 2204 | 0.120 |
Why?
|
| Th1 Cells | 3 | 2005 | 1042 | 0.120 |
Why?
|
| Psoriasis | 1 | 2023 | 926 | 0.120 |
Why?
|
| Crosses, Genetic | 6 | 2011 | 752 | 0.120 |
Why?
|
| Acetylation | 3 | 2015 | 1056 | 0.120 |
Why?
|
| Cell Line | 11 | 2014 | 15603 | 0.120 |
Why?
|
| Nucleoproteins | 2 | 1993 | 110 | 0.120 |
Why?
|
| Animals, Outbred Strains | 2 | 2010 | 20 | 0.110 |
Why?
|
| Cluster Analysis | 6 | 2014 | 2730 | 0.110 |
Why?
|
| Diarrhea | 1 | 2021 | 1319 | 0.110 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1996 | 481 | 0.110 |
Why?
|
| Viral Core Proteins | 2 | 1996 | 158 | 0.110 |
Why?
|
| Photochemical Processes | 1 | 2014 | 85 | 0.110 |
Why?
|
| Trans-Activators | 3 | 2017 | 2858 | 0.110 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2014 | 69 | 0.110 |
Why?
|
| Antibody Formation | 5 | 1993 | 1393 | 0.110 |
Why?
|
| Elasticity | 1 | 2015 | 657 | 0.110 |
Why?
|
| Receptors, Cell Surface | 1 | 2023 | 2820 | 0.110 |
Why?
|
| Immunophenotyping | 6 | 2015 | 1866 | 0.110 |
Why?
|
| Homeodomain Proteins | 2 | 1993 | 2431 | 0.110 |
Why?
|
| Ribonucleases | 2 | 1991 | 266 | 0.110 |
Why?
|
| Cyclophosphamide | 3 | 2005 | 2227 | 0.110 |
Why?
|
| Repressor Proteins | 4 | 2013 | 2986 | 0.110 |
Why?
|
| Serum | 1 | 2014 | 207 | 0.110 |
Why?
|
| Clone Cells | 6 | 2002 | 1670 | 0.100 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2020 | 1248 | 0.100 |
Why?
|
| Paralysis | 1 | 2014 | 250 | 0.100 |
Why?
|
| Receptors, Immunologic | 3 | 2014 | 1418 | 0.100 |
Why?
|
| Probiotics | 1 | 2016 | 382 | 0.100 |
Why?
|
| Immunogenetics | 1 | 2012 | 62 | 0.100 |
Why?
|
| Genes, Immunoglobulin | 1 | 1993 | 286 | 0.100 |
Why?
|
| Cytotoxicity, Immunologic | 2 | 1996 | 1356 | 0.100 |
Why?
|
| T-Lymphocytes, Cytotoxic | 4 | 1996 | 1803 | 0.100 |
Why?
|
| Genetic Predisposition to Disease | 8 | 2014 | 18065 | 0.100 |
Why?
|
| Bacterial Infections | 1 | 2021 | 1397 | 0.100 |
Why?
|
| CD4-CD8 Ratio | 3 | 2010 | 114 | 0.100 |
Why?
|
| STAT5 Transcription Factor | 1 | 2013 | 268 | 0.100 |
Why?
|
| Respiratory Hypersensitivity | 1 | 2014 | 272 | 0.100 |
Why?
|
| Neutralization Tests | 2 | 2009 | 739 | 0.100 |
Why?
|
| Tetracycline | 3 | 2005 | 216 | 0.100 |
Why?
|
| Graft Rejection | 3 | 1994 | 4492 | 0.100 |
Why?
|
| Recombinant Proteins | 6 | 2006 | 6512 | 0.100 |
Why?
|
| Nerve Fibers | 1 | 2016 | 709 | 0.100 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2014 | 615 | 0.100 |
Why?
|
| RNA Interference | 2 | 2014 | 2835 | 0.100 |
Why?
|
| Oligodeoxyribonucleotides | 4 | 1994 | 706 | 0.100 |
Why?
|
| Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2012 | 66 | 0.100 |
Why?
|
| Multigene Family | 3 | 2014 | 1082 | 0.100 |
Why?
|
| Mice, SCID | 3 | 2010 | 2631 | 0.100 |
Why?
|
| Immunohistochemistry | 5 | 2015 | 11119 | 0.100 |
Why?
|
| Mice, Inbred CBA | 4 | 2020 | 438 | 0.100 |
Why?
|
| Genes, Regulator | 3 | 1994 | 373 | 0.100 |
Why?
|
| Interferon Type I | 1 | 2016 | 569 | 0.100 |
Why?
|
| Microarray Analysis | 4 | 2012 | 755 | 0.100 |
Why?
|
| Isoenzymes | 1 | 1996 | 1687 | 0.100 |
Why?
|
| RNA | 3 | 2018 | 2727 | 0.100 |
Why?
|
| Receptors, Neurotransmitter | 1 | 2012 | 174 | 0.100 |
Why?
|
| Fetus | 3 | 2007 | 1882 | 0.100 |
Why?
|
| Protein Interaction Mapping | 1 | 2015 | 621 | 0.100 |
Why?
|
| RNA Processing, Post-Transcriptional | 3 | 2010 | 394 | 0.090 |
Why?
|
| Unfolded Protein Response | 1 | 2013 | 239 | 0.090 |
Why?
|
| Exons | 3 | 1992 | 2395 | 0.090 |
Why?
|
| Ion Channels | 1 | 2016 | 1044 | 0.090 |
Why?
|
| Cell Death | 3 | 2003 | 1682 | 0.090 |
Why?
|
| Microscopy, Confocal | 3 | 2013 | 1973 | 0.090 |
Why?
|
| Models, Molecular | 7 | 2017 | 5404 | 0.090 |
Why?
|
| Luminescent Proteins | 1 | 2014 | 839 | 0.090 |
Why?
|
| Muscular Dystrophies | 1 | 2013 | 393 | 0.090 |
Why?
|
| Peptide Fragments | 6 | 1999 | 5150 | 0.090 |
Why?
|
| Apoptosis | 4 | 2019 | 9528 | 0.090 |
Why?
|
| Fluorescence | 1 | 2013 | 758 | 0.090 |
Why?
|
| Sequence Analysis, RNA | 1 | 2019 | 2041 | 0.090 |
Why?
|
| Ankle | 1 | 2014 | 353 | 0.090 |
Why?
|
| Calcium Signaling | 1 | 2015 | 738 | 0.090 |
Why?
|
| Gene Rearrangement, B-Lymphocyte | 2 | 2006 | 111 | 0.090 |
Why?
|
| Oxidoreductases, O-Demethylating | 1 | 2010 | 4 | 0.090 |
Why?
|
| Nucleotides | 1 | 1993 | 455 | 0.090 |
Why?
|
| Skin | 2 | 2023 | 4507 | 0.090 |
Why?
|
| Mechanotransduction, Cellular | 1 | 2016 | 542 | 0.090 |
Why?
|
| Transplantation Immunology | 1 | 1993 | 537 | 0.090 |
Why?
|
| Orthomyxoviridae Infections | 1 | 1993 | 255 | 0.090 |
Why?
|
| Integrases | 2 | 2011 | 520 | 0.090 |
Why?
|
| Fibrinogen | 1 | 2014 | 892 | 0.090 |
Why?
|
| Mitochondrial Proteins | 1 | 2016 | 980 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 6 | 1 | 1991 | 370 | 0.090 |
Why?
|
| Epididymis | 1 | 2012 | 227 | 0.090 |
Why?
|
| Receptors, Interleukin-8B | 1 | 2010 | 58 | 0.090 |
Why?
|
| Membrane Proteins | 3 | 2012 | 7885 | 0.090 |
Why?
|
| Radiation Chimera | 2 | 2002 | 216 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1991 | 432 | 0.090 |
Why?
|
| Hybridization, Genetic | 2 | 2001 | 102 | 0.090 |
Why?
|
| Structure-Activity Relationship | 6 | 1994 | 3056 | 0.090 |
Why?
|
| Ferric Compounds | 1 | 2012 | 377 | 0.090 |
Why?
|
| Chromosome Deletion | 5 | 1999 | 1390 | 0.090 |
Why?
|
| Cell Cycle Proteins | 1 | 2021 | 3450 | 0.090 |
Why?
|
| Genetics, Population | 3 | 2015 | 944 | 0.080 |
Why?
|
| Protein Conformation | 6 | 2017 | 3956 | 0.080 |
Why?
|
| Albumins | 1 | 1992 | 577 | 0.080 |
Why?
|
| Immunoglobulin Allotypes | 1 | 1989 | 52 | 0.080 |
Why?
|
| B-Lymphocyte Subsets | 1 | 2011 | 241 | 0.080 |
Why?
|
| DNA-Activated Protein Kinase | 1 | 2010 | 111 | 0.080 |
Why?
|
| DNA-Directed RNA Polymerases | 1 | 2011 | 366 | 0.080 |
Why?
|
| Lymphocyte Depletion | 2 | 2009 | 605 | 0.080 |
Why?
|
| Transformation, Genetic | 1 | 1989 | 194 | 0.080 |
Why?
|
| Introns | 1 | 1992 | 969 | 0.080 |
Why?
|
| Sex Characteristics | 1 | 2020 | 2660 | 0.080 |
Why?
|
| Bacteriocins | 1 | 2009 | 85 | 0.080 |
Why?
|
| Plasmids | 4 | 2000 | 2269 | 0.080 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2000 | 3613 | 0.080 |
Why?
|
| DNA Topoisomerases, Type II | 1 | 2010 | 121 | 0.080 |
Why?
|
| Antigens, CD20 | 1 | 2010 | 199 | 0.080 |
Why?
|
| Thiazolidinediones | 1 | 2012 | 461 | 0.080 |
Why?
|
| Cytochrome c Group | 2 | 2000 | 123 | 0.080 |
Why?
|
| Immunity, Cellular | 4 | 2014 | 1560 | 0.080 |
Why?
|
| Operon | 4 | 1984 | 371 | 0.080 |
Why?
|
| Oligonucleotide Probes | 2 | 2004 | 417 | 0.080 |
Why?
|
| Ovum | 1 | 1989 | 187 | 0.080 |
Why?
|
| Simian virus 40 | 4 | 1984 | 292 | 0.080 |
Why?
|
| Adipokines | 1 | 2011 | 309 | 0.080 |
Why?
|
| Hematopoietic System | 1 | 2008 | 110 | 0.080 |
Why?
|
| Leukotrienes | 1 | 2010 | 232 | 0.080 |
Why?
|
| NFATC Transcription Factors | 2 | 2011 | 393 | 0.080 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 3 | 2021 | 306 | 0.080 |
Why?
|
| Oligonucleotides | 2 | 2007 | 563 | 0.080 |
Why?
|
| Receptors, Interleukin-7 | 2 | 2013 | 41 | 0.080 |
Why?
|
| Time Factors | 7 | 2012 | 40266 | 0.080 |
Why?
|
| Alternative Splicing | 1 | 2013 | 1105 | 0.080 |
Why?
|
| Enzyme Activation | 3 | 2014 | 3588 | 0.080 |
Why?
|
| Chromosome Inversion | 1 | 2008 | 119 | 0.070 |
Why?
|
| Transcription Initiation Site | 1 | 2008 | 190 | 0.070 |
Why?
|
| Lymphotoxin beta Receptor | 1 | 2007 | 26 | 0.070 |
Why?
|
| Antibody Specificity | 3 | 2009 | 1065 | 0.070 |
Why?
|
| Androstenes | 1 | 2009 | 186 | 0.070 |
Why?
|
| Immunoglobulin A | 2 | 2022 | 992 | 0.070 |
Why?
|
| Microsatellite Repeats | 2 | 2001 | 785 | 0.070 |
Why?
|
| Membrane Glycoproteins | 4 | 2003 | 3714 | 0.070 |
Why?
|
| Interleukin-12 | 2 | 2007 | 577 | 0.070 |
Why?
|
| Hypoglycemic Agents | 2 | 2012 | 3110 | 0.070 |
Why?
|
| Metal Nanoparticles | 1 | 2012 | 406 | 0.070 |
Why?
|
| Mucin-6 | 1 | 2007 | 15 | 0.070 |
Why?
|
| Heart | 2 | 2008 | 4448 | 0.070 |
Why?
|
| Methylation | 1 | 2010 | 1078 | 0.070 |
Why?
|
| DNA Repair | 1 | 2017 | 2054 | 0.070 |
Why?
|
| Serine Endopeptidases | 2 | 2012 | 1027 | 0.070 |
Why?
|
| Immunoprecipitation | 1 | 2010 | 874 | 0.070 |
Why?
|
| Superantigens | 2 | 1997 | 124 | 0.070 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2015 | 36861 | 0.070 |
Why?
|
| Antibody Affinity | 2 | 2002 | 253 | 0.070 |
Why?
|
| Child | 5 | 2024 | 80969 | 0.070 |
Why?
|
| Prodrugs | 1 | 2009 | 275 | 0.070 |
Why?
|
| Blood | 1 | 2009 | 597 | 0.070 |
Why?
|
| Mutagenesis | 3 | 2017 | 1229 | 0.070 |
Why?
|
| Cell Movement | 3 | 2014 | 5216 | 0.070 |
Why?
|
| DNA Damage | 1 | 2017 | 2472 | 0.070 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 1 | 2010 | 696 | 0.070 |
Why?
|
| Lymphopenia | 1 | 2009 | 299 | 0.070 |
Why?
|
| Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 2 | 1999 | 94 | 0.070 |
Why?
|
| Carrier Proteins | 1 | 2000 | 4940 | 0.070 |
Why?
|
| Diabetes Mellitus | 4 | 2011 | 5892 | 0.070 |
Why?
|
| H-Y Antigen | 2 | 1997 | 42 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 1658 | 0.070 |
Why?
|
| Bacterial Proteins | 1 | 2000 | 3839 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6242 | 0.070 |
Why?
|
| Antigens, Neoplasm | 2 | 2010 | 2001 | 0.070 |
Why?
|
| Cell Compartmentation | 2 | 1997 | 383 | 0.070 |
Why?
|
| Cross Reactions | 2 | 1999 | 828 | 0.070 |
Why?
|
| DNA, Bacterial | 1 | 2011 | 1478 | 0.070 |
Why?
|
| Substrate Specificity | 1 | 2010 | 1751 | 0.070 |
Why?
|
| Specific Pathogen-Free Organisms | 2 | 2012 | 220 | 0.070 |
Why?
|
| Neuropeptides | 1 | 2012 | 951 | 0.070 |
Why?
|
| Glycoproteins | 1 | 2013 | 2202 | 0.060 |
Why?
|
| Linkage Disequilibrium | 2 | 2010 | 1998 | 0.060 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2006 | 313 | 0.060 |
Why?
|
| Egg Proteins | 2 | 1999 | 58 | 0.060 |
Why?
|
| Tretinoin | 1 | 2008 | 525 | 0.060 |
Why?
|
| Spermatozoa | 1 | 1989 | 631 | 0.060 |
Why?
|
| Histological Techniques | 1 | 2005 | 194 | 0.060 |
Why?
|
| Bone Marrow Cells | 3 | 2012 | 2414 | 0.060 |
Why?
|
| Lupus Erythematosus, Systemic | 2 | 2003 | 2171 | 0.060 |
Why?
|
| Sequence Homology, Nucleic Acid | 3 | 1992 | 1057 | 0.060 |
Why?
|
| Computational Biology | 4 | 2014 | 3562 | 0.060 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2024 | 22 | 0.060 |
Why?
|
| Sequence Alignment | 3 | 2011 | 2179 | 0.060 |
Why?
|
| Endocrine System | 1 | 2005 | 113 | 0.060 |
Why?
|
| Neurodegenerative Diseases | 1 | 2014 | 1094 | 0.060 |
Why?
|
| Metabolic Networks and Pathways | 1 | 2009 | 800 | 0.060 |
Why?
|
| GATA6 Transcription Factor | 1 | 2024 | 54 | 0.060 |
Why?
|
| Gene Targeting | 2 | 2011 | 841 | 0.060 |
Why?
|
| Globins | 2 | 2000 | 405 | 0.060 |
Why?
|
| Liver | 2 | 2019 | 7579 | 0.060 |
Why?
|
| Cathepsins | 1 | 2005 | 242 | 0.060 |
Why?
|
| Binding, Competitive | 3 | 1990 | 1142 | 0.060 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2015 | 2460 | 0.060 |
Why?
|
| Neurogenesis | 1 | 2010 | 865 | 0.060 |
Why?
|
| Skin Transplantation | 3 | 1994 | 1097 | 0.060 |
Why?
|
| Bone Marrow Transplantation | 2 | 2010 | 2709 | 0.060 |
Why?
|
| Macrophages, Peritoneal | 1 | 2024 | 244 | 0.060 |
Why?
|
| DNA Probes | 1 | 2004 | 543 | 0.060 |
Why?
|
| Mucins | 1 | 2007 | 571 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 3 | 2017 | 7472 | 0.050 |
Why?
|
| Tumor Cells, Cultured | 3 | 2000 | 6131 | 0.050 |
Why?
|
| Carboxypeptidases A | 2 | 2014 | 28 | 0.050 |
Why?
|
| Jurkat Cells | 2 | 2020 | 739 | 0.050 |
Why?
|
| Pedigree | 1 | 2011 | 4545 | 0.050 |
Why?
|
| Sialoglycoproteins | 1 | 2004 | 320 | 0.050 |
Why?
|
| CARD Signaling Adaptor Proteins | 1 | 2024 | 165 | 0.050 |
Why?
|
| Viral Proteins | 2 | 2001 | 1802 | 0.050 |
Why?
|
| NIH 3T3 Cells | 2 | 2017 | 669 | 0.050 |
Why?
|
| Adolescent | 6 | 2021 | 89247 | 0.050 |
Why?
|
| Cysteine Endopeptidases | 1 | 2005 | 542 | 0.050 |
Why?
|
| Capillaries | 1 | 2006 | 756 | 0.050 |
Why?
|
| Receptors, Glucagon | 2 | 2013 | 90 | 0.050 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2008 | 2598 | 0.050 |
Why?
|
| Mice, Nude | 2 | 2007 | 3631 | 0.050 |
Why?
|
| Magnetics | 1 | 2005 | 599 | 0.050 |
Why?
|
| Mitosis | 1 | 2007 | 1181 | 0.050 |
Why?
|
| Capillary Permeability | 1 | 2006 | 773 | 0.050 |
Why?
|
| Terminology as Topic | 3 | 2013 | 1541 | 0.050 |
Why?
|
| Protein Kinase C-delta | 1 | 2002 | 115 | 0.050 |
Why?
|
| Cell Nucleus | 4 | 2020 | 2885 | 0.050 |
Why?
|
| Macromolecular Substances | 4 | 1991 | 1435 | 0.050 |
Why?
|
| Lectins, C-Type | 3 | 2013 | 593 | 0.050 |
Why?
|
| Lyme Disease Vaccines | 1 | 2001 | 18 | 0.050 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2016 | 2445 | 0.050 |
Why?
|
| Biological Transport | 3 | 1996 | 2085 | 0.050 |
Why?
|
| Microscopy, Electron | 3 | 1999 | 2560 | 0.050 |
Why?
|
| Case-Control Studies | 4 | 2021 | 22294 | 0.050 |
Why?
|
| Neurons | 1 | 2021 | 9524 | 0.050 |
Why?
|
| Models, Genetic | 4 | 2005 | 3446 | 0.050 |
Why?
|
| Nippostrongylus | 1 | 2021 | 21 | 0.050 |
Why?
|
| Mutagenesis, Insertional | 2 | 1995 | 662 | 0.050 |
Why?
|
| Phosphoproteins | 1 | 2010 | 2452 | 0.050 |
Why?
|
| Severity of Illness Index | 4 | 2021 | 15955 | 0.050 |
Why?
|
| Antigens, Surface | 3 | 2001 | 1616 | 0.050 |
Why?
|
| Capsid | 2 | 2001 | 435 | 0.050 |
Why?
|
| Nematospiroides dubius | 1 | 2021 | 37 | 0.050 |
Why?
|
| Keratitis, Herpetic | 1 | 2001 | 76 | 0.050 |
Why?
|
| DNA Methylation | 1 | 2015 | 4432 | 0.050 |
Why?
|
| Protein Kinases | 1 | 2008 | 1611 | 0.050 |
Why?
|
| Protein Multimerization | 2 | 2011 | 968 | 0.050 |
Why?
|
| Salmonella enterica | 1 | 2021 | 76 | 0.050 |
Why?
|
| Citrobacter rodentium | 1 | 2021 | 64 | 0.040 |
Why?
|
| Rabbits | 2 | 2000 | 4774 | 0.040 |
Why?
|
| Monocarboxylic Acid Transporters | 1 | 2020 | 81 | 0.040 |
Why?
|
| Blotting, Southern | 2 | 1991 | 777 | 0.040 |
Why?
|
| Succinates | 1 | 2020 | 83 | 0.040 |
Why?
|
| Cartilage | 1 | 2004 | 811 | 0.040 |
Why?
|
| Intranuclear Inclusion Bodies | 1 | 2020 | 34 | 0.040 |
Why?
|
| DNA Primers | 2 | 2002 | 2827 | 0.040 |
Why?
|
| Genome-Wide Association Study | 4 | 2014 | 12798 | 0.040 |
Why?
|
| DNA, Viral | 3 | 1981 | 2205 | 0.040 |
Why?
|
| DNA, Circular | 1 | 1980 | 97 | 0.040 |
Why?
|
| Antirheumatic Agents | 1 | 2010 | 1381 | 0.040 |
Why?
|
| Adenoviruses, Human | 1 | 1981 | 257 | 0.040 |
Why?
|
| Interleukin-18 | 1 | 2021 | 251 | 0.040 |
Why?
|
| Diagnostic Imaging | 2 | 2005 | 3538 | 0.040 |
Why?
|
| Mutagenesis, Site-Directed | 3 | 1996 | 1683 | 0.040 |
Why?
|
| Diabetic Nephropathies | 1 | 2007 | 973 | 0.040 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1990 | 2682 | 0.040 |
Why?
|
| Age of Onset | 1 | 2007 | 3346 | 0.040 |
Why?
|
| Genetic Linkage | 1 | 2005 | 2342 | 0.040 |
Why?
|
| Blood Glucose | 3 | 2013 | 6434 | 0.040 |
Why?
|
| Transcription Factor AP-1 | 1 | 2021 | 321 | 0.040 |
Why?
|
| Bacterial Vaccines | 1 | 2001 | 400 | 0.040 |
Why?
|
| Peptide Library | 1 | 2020 | 351 | 0.040 |
Why?
|
| Receptors, CCR2 | 1 | 2020 | 216 | 0.040 |
Why?
|
| Adult | 8 | 2021 | 223818 | 0.040 |
Why?
|
| Joint Diseases | 1 | 2002 | 461 | 0.040 |
Why?
|
| K562 Cells | 1 | 2020 | 648 | 0.040 |
Why?
|
| Epitopes, B-Lymphocyte | 1 | 1999 | 85 | 0.040 |
Why?
|
| Bacterial Outer Membrane Proteins | 1 | 2001 | 404 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 1990 | 1553 | 0.040 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 6546 | 0.040 |
Why?
|
| Enterovirus B, Human | 1 | 1998 | 49 | 0.040 |
Why?
|
| Esters | 1 | 2019 | 212 | 0.040 |
Why?
|
| Lymphocyte Subsets | 2 | 2006 | 313 | 0.040 |
Why?
|
| Restriction Mapping | 2 | 1989 | 849 | 0.040 |
Why?
|
| Hippocampus | 1 | 2010 | 3786 | 0.040 |
Why?
|
| Eye Proteins | 1 | 2001 | 628 | 0.040 |
Why?
|
| Pregnancy | 2 | 2017 | 30175 | 0.040 |
Why?
|
| Ovalbumin | 1 | 1999 | 677 | 0.040 |
Why?
|
| Selection, Genetic | 2 | 1995 | 878 | 0.040 |
Why?
|
| Interleukin-5 | 1 | 1998 | 267 | 0.040 |
Why?
|
| beta-Galactosidase | 1 | 1998 | 575 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2007 | 1813 | 0.040 |
Why?
|
| Symporters | 1 | 2020 | 363 | 0.040 |
Why?
|
| Receptors, Interferon | 1 | 1997 | 115 | 0.040 |
Why?
|
| Immunoglobulin G | 2 | 2009 | 4568 | 0.040 |
Why?
|
| Chemokine CCL2 | 1 | 2020 | 606 | 0.040 |
Why?
|
| Microscopy, Fluorescence | 3 | 2011 | 2635 | 0.040 |
Why?
|
| Diabetes Complications | 1 | 2004 | 1320 | 0.040 |
Why?
|
| Endothelium, Vascular | 1 | 2009 | 4428 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2017 | 26394 | 0.030 |
Why?
|
| Genome, Human | 2 | 2017 | 4456 | 0.030 |
Why?
|
| Lymphocyte Culture Test, Mixed | 2 | 1996 | 510 | 0.030 |
Why?
|
| Neurotransmitter Agents | 1 | 2021 | 665 | 0.030 |
Why?
|
| Immunoglobulin Class Switching | 1 | 1998 | 289 | 0.030 |
Why?
|
| Gene Knockdown Techniques | 2 | 2014 | 1608 | 0.030 |
Why?
|
| Chromatography | 1 | 1996 | 189 | 0.030 |
Why?
|
| Immunoglobulin D | 1 | 1996 | 55 | 0.030 |
Why?
|
| Lymphocytic Choriomeningitis | 1 | 1997 | 140 | 0.030 |
Why?
|
| Fluorescent Dyes | 2 | 2017 | 1933 | 0.030 |
Why?
|
| Genetic Complementation Test | 1 | 1997 | 557 | 0.030 |
Why?
|
| Transcription Factor RelA | 1 | 2017 | 254 | 0.030 |
Why?
|
| Glucose Tolerance Test | 1 | 2019 | 1183 | 0.030 |
Why?
|
| Bacterial Physiological Phenomena | 1 | 2017 | 120 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2020 | 642 | 0.030 |
Why?
|
| Muscular Dystrophy, Duchenne | 1 | 2019 | 271 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2011 | 9384 | 0.030 |
Why?
|
| Chimera | 2 | 1994 | 454 | 0.030 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2020 | 2488 | 0.030 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 1995 | 93 | 0.030 |
Why?
|
| Young Adult | 3 | 2021 | 60110 | 0.030 |
Why?
|
| Receptors, CXCR3 | 1 | 2016 | 240 | 0.030 |
Why?
|
| Muscle Contraction | 1 | 2020 | 1209 | 0.030 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2021 | 1105 | 0.030 |
Why?
|
| Histone Acetyltransferases | 1 | 2017 | 335 | 0.030 |
Why?
|
| Receptor, Interferon alpha-beta | 1 | 2016 | 113 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2005 | 1903 | 0.030 |
Why?
|
| Overweight | 1 | 2007 | 2445 | 0.030 |
Why?
|
| Bacteroidetes | 1 | 2015 | 84 | 0.030 |
Why?
|
| Lyme Disease | 1 | 2001 | 630 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 1999 | 1498 | 0.030 |
Why?
|
| Erythrocytes | 1 | 2004 | 2421 | 0.030 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1987 | 1731 | 0.030 |
Why?
|
| Algorithms | 2 | 2013 | 14199 | 0.030 |
Why?
|
| Synovial Membrane | 2 | 2009 | 536 | 0.030 |
Why?
|
| Chromosomal Proteins, Non-Histone | 1 | 1980 | 724 | 0.030 |
Why?
|
| Lymphocytic choriomeningitis virus | 1 | 1995 | 176 | 0.030 |
Why?
|
| Reproducibility of Results | 4 | 2018 | 20244 | 0.030 |
Why?
|
| Gene Rearrangement | 2 | 2007 | 1148 | 0.030 |
Why?
|
| Th1-Th2 Balance | 1 | 2014 | 38 | 0.030 |
Why?
|
| Genotype | 4 | 2014 | 13048 | 0.030 |
Why?
|
| Hybrid Cells | 2 | 1991 | 421 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 3 | 1 | 2015 | 474 | 0.030 |
Why?
|
| Nucleic Acid Conformation | 1 | 2017 | 901 | 0.030 |
Why?
|
| Protein Biosynthesis | 2 | 1992 | 2094 | 0.030 |
Why?
|
| T-Box Domain Proteins | 1 | 2016 | 472 | 0.030 |
Why?
|
| I-kappa B Proteins | 1 | 2014 | 210 | 0.030 |
Why?
|
| Rheumatic Fever | 1 | 2014 | 73 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2006 | 8559 | 0.030 |
Why?
|
| Lymphopoiesis | 1 | 2014 | 133 | 0.030 |
Why?
|
| Immunoglobulin Joining Region | 1 | 1993 | 37 | 0.030 |
Why?
|
| TATA-Box Binding Protein | 1 | 1993 | 99 | 0.030 |
Why?
|
| TATA Box | 1 | 1993 | 127 | 0.030 |
Why?
|
| Boron Compounds | 1 | 2015 | 196 | 0.030 |
Why?
|
| Hypersensitivity | 1 | 2003 | 1173 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2004 | 2589 | 0.030 |
Why?
|
| Submandibular Gland | 1 | 1993 | 85 | 0.030 |
Why?
|
| Templates, Genetic | 1 | 1993 | 188 | 0.030 |
Why?
|
| Protein Tyrosine Phosphatases | 1 | 2015 | 458 | 0.030 |
Why?
|
| Brain Diseases | 1 | 2002 | 1558 | 0.030 |
Why?
|
| Ionomycin | 1 | 1993 | 110 | 0.030 |
Why?
|
| Tandem Mass Spectrometry | 2 | 2010 | 1197 | 0.030 |
Why?
|
| Somatostatin | 1 | 2015 | 458 | 0.030 |
Why?
|
| Nucleocapsid Proteins | 1 | 1993 | 75 | 0.030 |
Why?
|
| Glucagon | 1 | 2015 | 534 | 0.030 |
Why?
|
| Disease Susceptibility | 1 | 2020 | 1794 | 0.030 |
Why?
|
| Antigens, Viral | 1 | 1997 | 996 | 0.030 |
Why?
|
| DNA, Recombinant | 3 | 1989 | 455 | 0.030 |
Why?
|
| Transcription Factor TFIID | 1 | 1993 | 150 | 0.030 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 1992 | 41 | 0.030 |
Why?
|
| Microcirculation | 2 | 2010 | 1281 | 0.030 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 478 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2001 | 1890 | 0.030 |
Why?
|
| Histone-Lysine N-Methyltransferase | 1 | 2017 | 701 | 0.030 |
Why?
|
| Bromodeoxyuridine | 1 | 1993 | 310 | 0.030 |
Why?
|
| Androgens | 1 | 2020 | 1285 | 0.030 |
Why?
|
| DNA Mutational Analysis | 2 | 1991 | 4123 | 0.030 |
Why?
|
| Chloramphenicol O-Acetyltransferase | 1 | 1992 | 221 | 0.030 |
Why?
|
| Alanine | 2 | 1996 | 614 | 0.030 |
Why?
|
| Influenza A virus | 2 | 1993 | 460 | 0.030 |
Why?
|
| Cyclic AMP | 1 | 1996 | 1470 | 0.030 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2012 | 48 | 0.030 |
Why?
|
| Lymphoid Enhancer-Binding Factor 1 | 1 | 2012 | 85 | 0.020 |
Why?
|
| Receptors, Neurotensin | 1 | 2012 | 16 | 0.020 |
Why?
|
| Host-Pathogen Interactions | 1 | 2021 | 1469 | 0.020 |
Why?
|
| Tetradecanoylphorbol Acetate | 1 | 1993 | 826 | 0.020 |
Why?
|
| Genetic Markers | 2 | 2010 | 2604 | 0.020 |
Why?
|
| Heterozygote | 1 | 1998 | 2798 | 0.020 |
Why?
|
| Heart Defects, Congenital | 1 | 2008 | 4711 | 0.020 |
Why?
|
| Zea mays | 1 | 1992 | 109 | 0.020 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 1991 | 141 | 0.020 |
Why?
|
| Stem Cell Factor | 1 | 2011 | 194 | 0.020 |
Why?
|
| Streptozocin | 1 | 2011 | 190 | 0.020 |
Why?
|
| GATA1 Transcription Factor | 1 | 2012 | 306 | 0.020 |
Why?
|
| Hemagglutinins, Viral | 1 | 1990 | 66 | 0.020 |
Why?
|
| Ikaros Transcription Factor | 1 | 2012 | 233 | 0.020 |
Why?
|
| Cell-Free System | 2 | 1981 | 340 | 0.020 |
Why?
|
| Salmonella Infections | 1 | 2012 | 172 | 0.020 |
Why?
|
| Enterotoxins | 1 | 1992 | 365 | 0.020 |
Why?
|
| Inbreeding | 1 | 2010 | 48 | 0.020 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 4356 | 0.020 |
Why?
|
| Receptors, Tumor Necrosis Factor | 2 | 2004 | 588 | 0.020 |
Why?
|
| In Situ Hybridization | 1 | 1995 | 1904 | 0.020 |
Why?
|
| Animals, Laboratory | 1 | 2010 | 46 | 0.020 |
Why?
|
| Age Factors | 2 | 1999 | 18454 | 0.020 |
Why?
|
| Genetic Drift | 1 | 2010 | 41 | 0.020 |
Why?
|
| Poly A | 1 | 1990 | 180 | 0.020 |
Why?
|
| Consensus Sequence | 1 | 2011 | 363 | 0.020 |
Why?
|
| Ankle Joint | 2 | 2007 | 452 | 0.020 |
Why?
|
| Deoxyribonucleases | 3 | 1984 | 209 | 0.020 |
Why?
|
| Biology | 1 | 2012 | 292 | 0.020 |
Why?
|
| Escherichia coli | 1 | 2022 | 4212 | 0.020 |
Why?
|
| X-Ray Diffraction | 1 | 1990 | 417 | 0.020 |
Why?
|
| Protein Structure, Quaternary | 1 | 2011 | 426 | 0.020 |
Why?
|
| Cattle | 2 | 1989 | 3820 | 0.020 |
Why?
|
| Science | 1 | 2012 | 236 | 0.020 |
Why?
|
| Integrin alpha Chains | 1 | 2010 | 93 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2005 | 14751 | 0.020 |
Why?
|
| Lod Score | 1 | 2010 | 600 | 0.020 |
Why?
|
| Listeriosis | 1 | 2010 | 147 | 0.020 |
Why?
|
| Amino Acids | 1 | 1996 | 1716 | 0.020 |
Why?
|
| Neoplasms | 1 | 2018 | 22390 | 0.020 |
Why?
|
| Molecular Structure | 1 | 2013 | 1885 | 0.020 |
Why?
|
| Phosphotyrosine | 1 | 2010 | 458 | 0.020 |
Why?
|
| Drug Synergism | 1 | 2013 | 1762 | 0.020 |
Why?
|
| Fungi | 1 | 1992 | 345 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 1992 | 818 | 0.020 |
Why?
|
| Eosinophils | 1 | 2014 | 953 | 0.020 |
Why?
|
| Gene Knock-In Techniques | 1 | 2010 | 422 | 0.020 |
Why?
|
| Magnetite Nanoparticles | 1 | 2010 | 313 | 0.020 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2011 | 859 | 0.020 |
Why?
|
| DNA Restriction Enzymes | 3 | 1983 | 548 | 0.020 |
Why?
|
| Horses | 1 | 1989 | 296 | 0.020 |
Why?
|
| Dextrans | 1 | 2010 | 574 | 0.020 |
Why?
|
| Listeria monocytogenes | 1 | 2010 | 246 | 0.020 |
Why?
|
| Ki-67 Antigen | 1 | 2010 | 628 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1993 | 2475 | 0.020 |
Why?
|
| Middle Aged | 5 | 2021 | 223740 | 0.020 |
Why?
|
| Antigen-Antibody Reactions | 1 | 1988 | 342 | 0.020 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2012 | 627 | 0.020 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 1 | 2008 | 64 | 0.020 |
Why?
|
| Proteins | 2 | 1993 | 6011 | 0.020 |
Why?
|
| HLA-DQ Antigens | 1 | 2008 | 190 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 2000 | 2543 | 0.020 |
Why?
|
| Protein Array Analysis | 1 | 2009 | 400 | 0.020 |
Why?
|
| Gene Library | 1 | 1990 | 1062 | 0.020 |
Why?
|
| Glycolysis | 1 | 2012 | 838 | 0.020 |
Why?
|
| Centrifugation, Density Gradient | 1 | 1987 | 298 | 0.020 |
Why?
|
| Neutrophil Infiltration | 1 | 2010 | 395 | 0.020 |
Why?
|
| Androstadienes | 1 | 2009 | 348 | 0.020 |
Why?
|
| Cell Membrane Permeability | 1 | 2009 | 573 | 0.020 |
Why?
|
| Blood Component Transfusion | 1 | 2008 | 141 | 0.020 |
Why?
|
| Bone Marrow | 1 | 1997 | 2935 | 0.020 |
Why?
|
| Glutamates | 1 | 1988 | 385 | 0.020 |
Why?
|
| Mitochondria | 1 | 2020 | 3683 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 1990 | 1705 | 0.020 |
Why?
|
| Embryo, Mammalian | 1 | 1993 | 1676 | 0.020 |
Why?
|
| Sheep | 1 | 1989 | 1451 | 0.020 |
Why?
|
| Transplantation, Heterologous | 1 | 2015 | 2395 | 0.020 |
Why?
|
| Protein Processing, Post-Translational | 1 | 2014 | 1966 | 0.020 |
Why?
|
| Homozygote | 1 | 1991 | 1779 | 0.020 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2012 | 1151 | 0.020 |
Why?
|
| Leukocyte Count | 1 | 2010 | 1609 | 0.020 |
Why?
|
| Random Allocation | 1 | 2011 | 2396 | 0.020 |
Why?
|
| Encephalomyelitis, Autoimmune, Experimental | 1 | 2011 | 822 | 0.020 |
Why?
|
| Chelating Agents | 1 | 1987 | 385 | 0.020 |
Why?
|
| Chemokines | 1 | 2010 | 963 | 0.020 |
Why?
|
| Tamoxifen | 1 | 2010 | 967 | 0.020 |
Why?
|
| Cathepsin L | 1 | 2005 | 69 | 0.020 |
Why?
|
| Data Display | 1 | 2006 | 174 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2011 | 2067 | 0.020 |
Why?
|
| Cross-Linking Reagents | 1 | 1989 | 692 | 0.020 |
Why?
|
| Immunoglobulin E | 1 | 2011 | 1506 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 941 | 0.020 |
Why?
|
| Transduction, Genetic | 1 | 2008 | 902 | 0.020 |
Why?
|
| Dimerization | 1 | 2006 | 886 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2008 | 725 | 0.010 |
Why?
|
| Luciferases | 1 | 2006 | 713 | 0.010 |
Why?
|
| Glucocorticoid-Induced TNFR-Related Protein | 1 | 2004 | 40 | 0.010 |
Why?
|
| Anaphylaxis | 1 | 2011 | 758 | 0.010 |
Why?
|
| Stem Cell Transplantation | 1 | 1993 | 1602 | 0.010 |
Why?
|
| Computer Simulation | 2 | 2010 | 6289 | 0.010 |
Why?
|
| Antibodies, Viral | 1 | 1996 | 3216 | 0.010 |
Why?
|
| Rats | 2 | 2012 | 23847 | 0.010 |
Why?
|
| Histamine | 1 | 2006 | 496 | 0.010 |
Why?
|
| Research | 1 | 2012 | 1981 | 0.010 |
Why?
|
| OX40 Ligand | 1 | 2003 | 57 | 0.010 |
Why?
|
| Placebos | 1 | 2008 | 1668 | 0.010 |
Why?
|
| Tumor Necrosis Factors | 1 | 2003 | 109 | 0.010 |
Why?
|
| Interleukins | 1 | 2008 | 796 | 0.010 |
Why?
|
| Gastritis | 1 | 2005 | 199 | 0.010 |
Why?
|
| Lentivirus | 1 | 2006 | 520 | 0.010 |
Why?
|
| Cell Membrane | 1 | 1993 | 3659 | 0.010 |
Why?
|
| Receptors, Nerve Growth Factor | 1 | 2004 | 200 | 0.010 |
Why?
|
| Colitis, Ulcerative | 1 | 2015 | 1931 | 0.010 |
Why?
|
| Child, Preschool | 2 | 2021 | 42684 | 0.010 |
Why?
|
| Immunotherapy, Adoptive | 1 | 1993 | 1519 | 0.010 |
Why?
|
| Tarsus, Animal | 1 | 2002 | 5 | 0.010 |
Why?
|
| Phylogeny | 1 | 2010 | 2843 | 0.010 |
Why?
|
| Cell Adhesion | 1 | 2009 | 3102 | 0.010 |
Why?
|
| Osteopontin | 1 | 2004 | 311 | 0.010 |
Why?
|
| Glutamic Acid | 1 | 1988 | 1193 | 0.010 |
Why?
|
| Genes, T-Cell Receptor | 1 | 2001 | 29 | 0.010 |
Why?
|
| Aged | 3 | 2021 | 171790 | 0.010 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2006 | 2749 | 0.010 |
Why?
|
| Micrococcal Nuclease | 2 | 1978 | 36 | 0.010 |
Why?
|
| Disease | 1 | 2007 | 673 | 0.010 |
Why?
|
| Crystallography, X-Ray | 1 | 2006 | 1952 | 0.010 |
Why?
|
| Cell Degranulation | 1 | 2002 | 277 | 0.010 |
Why?
|
| Extracellular Matrix | 1 | 2009 | 1739 | 0.010 |
Why?
|
| Osteoarthritis | 1 | 2009 | 1070 | 0.010 |
Why?
|
| Spondylitis, Ankylosing | 1 | 2003 | 159 | 0.010 |
Why?
|
| Pilot Projects | 1 | 2015 | 8742 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type I | 1 | 2002 | 257 | 0.010 |
Why?
|
| Meta-Analysis as Topic | 1 | 2006 | 1364 | 0.010 |
Why?
|
| Gene Frequency | 1 | 2008 | 3625 | 0.010 |
Why?
|
| Serotonin | 1 | 2006 | 1045 | 0.010 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 2960 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2012 | 8200 | 0.010 |
Why?
|
| Molecular Weight | 1 | 1983 | 2173 | 0.010 |
Why?
|
| Genes, Viral | 1 | 1981 | 655 | 0.010 |
Why?
|
| Nucleosomes | 2 | 1984 | 492 | 0.010 |
Why?
|
| Receptors, Tumor Necrosis Factor, Type II | 1 | 2002 | 348 | 0.010 |
Why?
|
| Arthritis, Psoriatic | 1 | 2003 | 219 | 0.010 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1983 | 648 | 0.010 |
Why?
|
| Immunization, Passive | 1 | 2002 | 619 | 0.010 |
Why?
|
| Chemistry | 1 | 1980 | 327 | 0.010 |
Why?
|
| Parkinson Disease | 1 | 2014 | 2896 | 0.010 |
Why?
|
| Incidence | 1 | 1998 | 21545 | 0.010 |
Why?
|
| Lysosomes | 1 | 2005 | 940 | 0.010 |
Why?
|
| Viral Envelope Proteins | 2 | 1996 | 641 | 0.010 |
Why?
|
| High Mobility Group Proteins | 1 | 1980 | 179 | 0.010 |
Why?
|
| Chemical Phenomena | 1 | 1980 | 486 | 0.010 |
Why?
|
| Laparoscopy | 1 | 2011 | 2055 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2012 | 4528 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 4784 | 0.010 |
Why?
|
| Swine | 1 | 1989 | 5998 | 0.010 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2011 | 3671 | 0.010 |
Why?
|
| Multiple Sclerosis | 1 | 2014 | 3250 | 0.010 |
Why?
|
| Genes | 1 | 1983 | 1824 | 0.010 |
Why?
|
| TOR Serine-Threonine Kinases | 1 | 2008 | 2063 | 0.010 |
Why?
|
| Infant | 1 | 2021 | 36541 | 0.010 |
Why?
|
| Interleukin-10 | 1 | 2004 | 1184 | 0.010 |
Why?
|
| Calcium | 1 | 2012 | 5792 | 0.010 |
Why?
|
| Genes, MHC Class I | 1 | 1999 | 236 | 0.010 |
Why?
|
| Pancreatitis | 1 | 2005 | 1087 | 0.010 |
Why?
|
| Tetrahymena pyriformis | 1 | 1978 | 2 | 0.010 |
Why?
|
| Cohort Studies | 1 | 2021 | 41800 | 0.010 |
Why?
|
| Butyrates | 1 | 1978 | 167 | 0.010 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 1995 | 9081 | 0.010 |
Why?
|
| Sarcoidosis | 1 | 2003 | 535 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2002 | 1505 | 0.010 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2015 | 5716 | 0.010 |
Why?
|
| RNA Polymerase II | 1 | 1981 | 549 | 0.010 |
Why?
|
| Ribosomes | 1 | 1980 | 499 | 0.010 |
Why?
|
| Blood Transfusion | 1 | 2002 | 1309 | 0.010 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 12093 | 0.010 |
Why?
|
| Cartilage, Articular | 1 | 2002 | 1104 | 0.010 |
Why?
|
| Lung | 1 | 1993 | 10097 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 17174 | 0.010 |
Why?
|
| Endosomes | 1 | 1996 | 525 | 0.010 |
Why?
|
| Protein Structure, Secondary | 1 | 1996 | 1216 | 0.010 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 1996 | 567 | 0.010 |
Why?
|
| Lymphoma, Large B-Cell, Diffuse | 1 | 1983 | 1437 | 0.010 |
Why?
|
| Alzheimer Disease | 1 | 2014 | 8758 | 0.010 |
Why?
|
| HeLa Cells | 1 | 1978 | 3076 | 0.010 |
Why?
|
| Arginine | 1 | 1996 | 932 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 10778 | 0.010 |
Why?
|
| Peptide Mapping | 1 | 1990 | 260 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2003 | 2297 | 0.010 |
Why?
|
| Trypsin | 1 | 1990 | 491 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 1996 | 1133 | 0.010 |
Why?
|
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 1990 | 164 | 0.010 |
Why?
|
| Interleukin-3 | 1 | 1990 | 425 | 0.010 |
Why?
|
| Immunization | 1 | 1993 | 1219 | 0.010 |
Why?
|
| Chickens | 1 | 1989 | 845 | 0.000 |
Why?
|
| Brain | 1 | 1989 | 27476 | 0.000 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1984 | 781 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2008 | 65485 | 0.000 |
Why?
|
| Risk Factors | 1 | 2008 | 74971 | 0.000 |
Why?
|
| DNA Replication | 1 | 1984 | 1428 | 0.000 |
Why?
|
| Solubility | 1 | 1978 | 1087 | 0.000 |
Why?
|